March 12, 2019

Cell Medica Earns $8.7 Million Grant to Accelerate Off-the-shelf CAR-NKT Cell Therapy

News

Aiming to support the development of CMD-502, a new cell-based therapy that uses donor-derived natural killer T-cells to fight cancer, the Cancer Prevention and Research Institute of Texas (CPRIT) has awarded Cell Medica an $8.7 ... Read more

October 29, 2018

Targeting B-cell Lymphoma with Natural Killer T-cells May Be More Effective, Cheaper, Preclinical Study Shows

News

Targeting B-cell lymphoma using genetically modified natural killer T-cells — rather than general T-cells — may be a more effective, cheaper, “off-the-shelf” immunotherapy, a preclinical study suggests. The study, “Enhanced ... Read more